Sentara Infusion Services recalls PENICILLIN (a) 40MU IN D5W 400ML(CONTINUOUS), (b) 40U IN D5W 400ML(CONTINUOUS), (c) 48MU IN D5W 480ML, antibiotic, Rx O…
- Recall date
- December 27, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0314-2023
- FDA classification
- Class II
- Brand / firm
- Sentara Infusion Services
- Sold / distributed
- Dispensed to Patients Nationwide.
Why it was recalled
Lack of sterility assurance
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PENICILLIN (a) 40MU IN D5W 400ML(CONTINUOUS), (b) 40U IN D5W 400ML(CONTINUOUS), (c) 48MU IN D5W 480ML, antibiotic, Rx Only, use with a Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Get recall alerts
Free email alert whenever Sentara Infusion Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Infusion Services